URETHANE INTERFERES WITH THE ALPHA-2-AGONIST GUANFACINE

被引：10

作者：

MOORE, ND

CHADELAUD, M

HUCHET, AM

SALIGAUT, C

DAOUST, M

LHUINTRE, JP

CHRETIEN, P

BOISMARE, F

机构：

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1984年 / 6卷 / 05期

关键词：

D O I：

10.1097/00005344-198409000-00036

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：973 / 974

页数：2

共 14 条

[1]

ANTONACCIO MJ, 1984, CARDIOVASCULAR PHARM

[2]

ARMSTRONG JM, 1982, J PHARMACOL EXP THER, V223, P524

[3]

ARMSTRONG JM, 1981, BRIT J PHARMACOL, V72, pP107

[4]

BOWMAN WC, 1981, EFFECTS ADRENERGIC 2, P66

[5]

Bowman WC, 1968, TXB PHARM

[6]

DOMER FR, 1971, ANIMAL EXPT PHARM AN

[7]

Goodman LS., 1975, PHARM BASIS THERAPEU

[8] PREJUNCTIONAL MODULATION OF NORADRENALINE RELEASE BY ALPHA-2-ADRENOCEPTORS - PHYSIOLOGICAL AND PHARMACOLOGICAL IMPLICATIONS IN THE CARDIOVASCULAR-SYSTEM [J].

LANGER, SZ ;

SHEPPERSON, NB .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 :S35-S40

[9] PRESYNAPTIC REGULATION OF CATECHOLAMINE RELEASE [J].

LANGER, SZ .

BIOCHEMICAL PHARMACOLOGY, 1974, 23 (13) :1793-1800

[10] NEW DEVELOPMENTS IN ALPHA-ADRENORECEPTOR DRUGS FOR THE TREATMENT OF HYPERTENSION [J].

LOUIS, WJ ;

SUMMERS, RJ ;

DYNON, M ;

JARROTT, B .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 :S168-S171

← 1 2 →